Cargando…
Progress in Therapy Development for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that cannot be slowed substantially using any currently-available clinical tools. Through decades of studying sporadic and familial ALS (SALS and FALS), researchers are coming to understand ALS as a complex syndrome with...
Autores principales: | Venkova-Hristova, Kalina, Christov, Alexandar, Kamaluddin, Zarine, Kobalka, Peter, Hensley, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399448/ https://www.ncbi.nlm.nih.gov/pubmed/22830014 http://dx.doi.org/10.1155/2012/187234 |
Ejemplares similares
-
Erratum to “Progress in Therapy Development for Amyotrophic Lateral Sclerosis”
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012) -
Semaphorin 3A Signaling Through Neuropilin-1 Is an Early Trigger for Distal Axonopathy in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Venkova, Kalina, et al.
Publicado: (2014) -
Emerging Biological Importance of Central Nervous System Lanthionines
por: Hensley, Kenneth, et al.
Publicado: (2010) -
Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012) -
Gene Therapy in Amyotrophic Lateral Sclerosis
por: Fang, Ton, et al.
Publicado: (2022)